CYTK: Cytokinetics Incorporated
CYTK exchange rate has changed by -1.66% for today. During the day, the instrument was traded at a low of 72.26 and at a high of 73.85.
Follow Cytokinetics Incorporated dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CYTK News
- Will Camzyos' Long-Term Benefits Strengthen BMY's Growth Outlook?
- Can CYTK's Aficamten Strengthen Its HCM Growth Prospects?
- What's Going On With Cytokinetics Stock Today? - Cytokinetics (NASDAQ:CYTK)
- Cytokinetics, Incorporated (CYTK) Discusses Positive Phase III Results From ACACIA-HCM Trial of Aficamten in Nonobstructive HCM Transcript
- Cytokinetics Scores A First-Ever In Its Rivalry Against Bristol Myers
- Can Camzyos' Growth Offset Bristol Myers' Patent Pressures?
- Cytokinetics Gains 20.5% YTD: Buy, Sell or Hold the Stock?
- CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong
- Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates
- Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for
- Cytokinetics (CYTK) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- Are Medical Stocks Lagging Concentra Group Holdings Parent, Inc. (CON) This Year?
- All You Need to Know About Cytokinetics (CYTK) Rating Upgrade to Buy
- Wall Street Analysts Think Cytokinetics (CYTK) Could Surge 30.54%: Read This Before Placing a Bet
- Apple Shines As It Nears Fresh High, Leads 18 Hot Picks Onto Best Stock Lists
- Will Myqorzo Drive Cytokinetics Higher Despite Competitive Pressure?
- AMD, Micron Spearhead Chip Sector Surge, Lead 23 Hot Prospects To Best Stock Lists
- Entertainment Stocks Madison Square Garden, Sphere Rally To New Highs
- Cytokinetics Gains 18.4% Year to Date: How to Play the Stock?
- Can BMY's Camzyos Strengthen Its Cardiovascular Portfolio?
Frequently Asked Questions
What is CYTK stock price today?
Cytokinetics Incorporated stock is priced at 72.72 today. It trades within 72.26 - 73.85, yesterday's close was 73.95, and trading volume reached 2376. The live price chart of CYTK shows these updates.
Does Cytokinetics Incorporated stock pay dividends?
Cytokinetics Incorporated is currently valued at 72.72. Dividend policy depends on the company, while investors also watch 25.16% and USD. View the chart live to track CYTK movements.
How to buy CYTK stock?
You can buy Cytokinetics Incorporated shares at the current price of 72.72. Orders are usually placed near 72.72 or 73.02, while 2376 and -0.44% show market activity. Follow CYTK updates on the live chart today.
How to invest into CYTK stock?
Investing in Cytokinetics Incorporated involves considering the yearly range 57.83 - 88.31 and current price 72.72. Many compare 3.66% and 9.45% before placing orders at 72.72 or 73.02. Explore the CYTK price chart live with daily changes.
What are Cytokinetics Incorporated stock highest prices?
The highest price of Cytokinetics Incorporated in the past year was 88.31. Within 57.83 - 88.31, the stock fluctuated notably, and comparing with 73.95 helps spot resistance levels. Track Cytokinetics Incorporated performance using the live chart.
What are Cytokinetics Incorporated stock lowest prices?
The lowest price of Cytokinetics Incorporated (CYTK) over the year was 57.83. Comparing it with the current 72.72 and 57.83 - 88.31 shows potential long-term entry points. Watch CYTK moves on the chart live for more details.
When did CYTK stock split?
Cytokinetics Incorporated has gone through stock splits historically. These changes are visible in , 73.95, and 25.16% after corporate actions.
- Previous Close
- 73.95
- Open
- 73.04
- Bid
- 72.72
- Ask
- 73.02
- Low
- 72.26
- High
- 73.85
- Volume
- 2.376 K
- Daily Change
- -1.66%
- Month Change
- 3.66%
- 6 Months Change
- 9.45%
- Year Change
- 25.16%